Merck & Company Inc
Stock Chart, Company Information, and Scan Results
$78.49(as of Sep 29, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Merck & Company Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$78.49
Ticker SymbolMRK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
CountyUSA
Market Cap$196,225.8M
EBIDTA28,330.0M
P/E Ratio12.04
Forward P/E Ratio8.02
Earnings per Share6.49
Profit Margin28.01%
RSI37.10
Shares Outstanding2,497.8M
ATR1.50
52-Week High110.69
Volume12,735,746
52-Week Low71.87
Book Value49,060.0M
P/B Ratio4.03
Upper Keltner85.00
P/S Ratio3.10
Lower Keltner78.27
Debt-to-Equity Ratio85.00
Next Earnings Date10/30/2025
Cash Surplus-18,030.0M
Next Ex-Dividend DateUnknown
This pharmaceutical company is responsible for one of the best-selling drugs worldwide. Their blockbuster drug, Keytruda, is designed to treat certain types of cancer and is the company’s main revenue driver. They are also behind the development of Gardasil—a vaccine for HPV that has helped prevent hundreds of thousands of cases of cervical cancer.
Merck & Company Inc In Our Stock Scanner
As of Sep 30, 2025
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.